John Goldfinch

Statistics

Publications

Citations

H-Index

Active since

2020

Affiliations

Instituto Nacional de Diabetes, Endocrinología y Nutrición(Current)

John Goldfinch is an author at Instituto Nacional de Diabetes, Endocrinología y Nutrición specializing in tumor response evaluation, metastatic breast cancer, and trough concentrations.

Publications per year

2020–2025

Publications

The oncolytic adenovirus TILT-123 with pembrolizumab in platinum resistant or refractory ovarian cancer: the phase 1a PROTA trial

Matthew S. Block, James H.A. Clubb, Johanna Mäenpää et al. · Nature Communications · 2025 · 29 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Abstract GS6-01: Oral paclitaxel with encequidar: The first orally administered paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: A phase III clinical study in metastatic breast cancer

Gerardo Umanzor, David L. Cutler, Francisco Barrios et al. · Cancer Research · 2020 · 12 citations

Medicine, Oncology, Pharmacology +17

1–2 of 2